Rallybio Corporation
RLYB
$0.298
-$0.0029-0.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -87.29% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -87.29% | 0.00% | |||
| Cost of Revenue | -10.38% | -36.35% | |||
| Gross Profit | 7.48% | 37.21% | |||
| SG&A Expenses | 3.30% | -5.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.81% | -28.67% | |||
| Operating Income | 3.80% | 29.17% | |||
| Income Before Tax | 3.68% | 29.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.68% | 29.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.68% | 29.38% | |||
| EBIT | 3.80% | 29.17% | |||
| EBITDA | 3.79% | 29.22% | |||
| EPS Basic | 3.81% | 30.12% | |||
| Normalized Basic EPS | 3.80% | 30.13% | |||
| EPS Diluted | 3.81% | 30.12% | |||
| Normalized Diluted EPS | 3.80% | 30.13% | |||
| Average Basic Shares Outstanding | 0.15% | 1.05% | |||
| Average Diluted Shares Outstanding | 0.15% | 1.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||